Taiwan to fully subsidize newborn screening from July, adding SMA tests

Taiwan is set to enhance its newborn healthcare services by fully subsidizing newborn screening and expanding the number of detectable conditions. Starting July 1, the National Health Insurance Administration (NHIA) will cover the full cost of newborn screening, a significant increase from previous partial subsidies. This move is part of a broader effort to bolster preventive healthcare measures for newborns in the face of declining birth rates.

The expanded screening program will now include 22 items, with the addition of Spinal Muscular Atrophy (SMA), a serious genetic disorder. Previously, 21 congenital metabolic abnormalities were screened. The aim is to detect these conditions early through a small blood sample taken from newborns within 48 hours of birth, allowing for timely intervention and minimizing potential harm to the child's development.

In addition to newborn screening, the NHIA is also increasing the number of recommended child preventive healthcare visits from the current seven to nine. These visits will include comprehensive health check-ups and health education for parents, focusing on crucial aspects like vision, hearing, feeding habits, and injury prevention. Prenatal genetic diagnostic testing subsidies are also being raised, with the subsidy for genetic diagnostic tests increasing from NT$5,000 to NT$7,000, and for blood cell genetic tests from NT$1,500 to NT$3,500.

These initiatives are expected to benefit over 100,000 newborns annually through the expanded screening and an estimated over 43,000 expectant mothers through increased prenatal testing subsidies. The government hopes these measures will support parents in monitoring their children's health more effectively and ensure timely medical interventions.